A woman was told she had Alzheimer’s 13 years ago. Now she’s walking the width of the U.S. after reversing her illness - US ...

A new study led by scientists from BGI Genomics' Institute of Intelligent Medical Research (IIMR) has identified early ...

The FDA expanded the uses of GE HealthCare’s Vizamyl imaging agent for highlighting the presence of beta amyloid proteins in ...

The US Food and Drug Administration (FDA) has granted approval for a label update to Eli Lilly and Company's Amyvid ...

The FDA has approved expanded use of GE HealthCare’s PET imaging agent, Vizamyl, for improved detection and monitoring of Alzheimer’s disease. The updated label now allows Vizamyl to be used to detect ...

In searching for a possible therapeutic target to stop the progress of this disease, an international scientific team, led by ...

A new way of thinking about Alzheimer’s disease has yielded a discovery that could be the key to stopping the cognitive decline seen in Alzheimer’s and other neurodegenerative diseases, according ...

Indianapolis: Eli Lilly and Company has recieved approval from the U.S. Food and Drug Administration (U.S. FDA) for a label ...

More than 7 million people have Alzheimer’s disease here in the United States. Now, a new blood test may be able to help with ...

The label update for Amyvid adds guidance for assessing amyloid plaque levels and may help inform diagnostic and treatment ...

It’s a disease that impacts memory, behavior, and ultimately, independence. Alzheimer’s disease is the most common form of ...

Our federal lawmakers should substantial and sustained investments for Alzheimer’s research funding and the dementia public ...